Getting oncolytic virus therapies off the ground
Open Access
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 4 (1) , 7-11
- https://doi.org/10.1016/s1535-6108(03)00170-3
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell markerBlood, 2003
- Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) proteinCancer Gene Therapy, 2003
- Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy, 2002
- TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha geneCancer Gene Therapy, 2002
- Efficiency of Measles Virus Entry and Dissemination through Different ReceptorsJournal of Virology, 2002
- Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cellsGene Therapy, 2002
- Tumor-specific transcriptional targeting of suicide gene therapyGene Therapy, 2002
- Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particlesThe Journal of Gene Medicine, 2001
- Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K ProteinJournal of Virology, 2001
- Targeting of adenoviral vectors for gene therapy of prostate cancerProstate Cancer and Prostatic Diseases, 2000